Real Chemistry Delivers Double-Digit Year-Over-Year Growth in 2025 as Tier-One, Tech-Enabled Healthcare Commercialization Partner
Read More 2 minute read Business BaroPace, Inc. Announced First Patient Enrolled in Non-Pharmacologic Hypertension and Heart Failure Treatment Trial SAMMAMISH, Wash. — BaroPace Inc., a medical device company focused on the development of PressurePace™, a real-time physiologic… byKarrenAugust 22, 2023